Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...
Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...
A wireless electronic prosthesis implanted under the retina has been shown to restore central vision in people with an advanced form of dry age-related macular degeneration, leading to improvement in ...
Geographic atrophy is a growing worldwide health issue, with approximately 8 million patients impacted, according to a ...
Ocugen also reported updated results from a phase 1 trial, which showed that ellipsoid zone (EZ) loss – which results in the ...
—Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness. It ...